Article metrics

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial

 

Online download statistics by month:

Online download statistics by month: September 2019 to October 2020

AbstractFullPdf
Sep 201910171016453
Oct 2019386338431796
Nov 201919871957872
Dec 201916911660667
Jan 202017071674664
Feb 202013051277531
Mar 202010991066457
Apr 2020795774348
May 2020870860439
Jun 2020858835399
Jul 2020810768462
Aug 2020732697274
Sep 2020811785343
Oct 2020790772406
Total18335179848111